Phase 3 Trial
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Phase 3 Trial
Jul 19, 2024, 22:56 |
Insight
Stunning interim clinical trial data from Revolution Medicines
Grainne O'Kane, Medical Oncologist at Princess Margaret Cancer Centre, shared a post by Kenneth Olive,…
Jul 2, 2024, 08:18 |
Blog
Naveen Pemmaraju: Navitoclax and Ruxolitinib in Patients With Untreated Myelofibrosis
Naveen Pemmaraju shared a post on LinkedIn: “A huge shout out to all of you…
Jun 27, 2024, 11:10 |
Blog
Press release from the PRESERVE 2 phase 3 trial
Paolo Tarantino shared a post on X: “Press release from the PRESERVE 2 phase 3…
May 2, 2024, 11:41 |
Insight
Erman Akkus summarizes Adjuvant Aspirin in Breast Cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Adjuvant Aspirin in Breast Cancer…
May 1, 2024, 13:41 |
Opinion
Sara Tolaney: Such an important question addressed in the Alliance A011502 study
Sara Tolaney shared a post by Erman Akkus, Medical Oncology Fellow at Ankara University, on X/Twitter: "Such…
Mar 4, 2024, 17:58 |
Insight
Paolo Tarantino: You don’t always need a fancy new drug to impact patients QoL
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
All:
6
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube